Next, to investigate the relationship between IGFBP3 and the immune checkpoint ligand PD-L1, we collected gene expression data of IGFBP3 and PD-L1 of patients diagnosed with LGG (n = 418) and GBM (n = 152) from the TCGA. The gene discussed is IGFBP3; the disease is glioblastoma.